Applied Cardiac Systems Inc (ACS) has been a leading provider of Ambulatory ECG devices (Holter & Event Monitoring) technology for more than 33 years. ACS had a successful run in ECP with more active placements in the U.S than any other ECP company. ACS recently sold their ECP technology to the Renew Group in Farmington Hills, Michigan.
ACS experienced immediate success in U.S. External Counterpulsation Therapy marketplace by leveraging the long-time relationships they had developed in Cardiology with their cardiac monitoring systems. Within just a few short years, ACS had nearly 30% of the U.S. ECP market-share which had previously been dominated by Vasomedical. This quick growth can be attributed to providing a high quality ECP technology at a fraction of the cost of the competition.
ACS takes pride in having developed significant improvements in ECP device technology. The technological advancements had notable success against the competition because the system is said to be quieter, generate less heat, more reliable at a significantly lower price tag. The NCP systems offered a unique automatic treatment report that automates the process for the therapist. The improved software automation, automatic treatment report and recording all ECP treatment information was a big selling feature versus other antiquated systems. Further, the NCP system treatment platform can be used for multiple applications such as an exam table & echo platform when not in use for ECP therapy.
After the acquisition, the NCP Plus is no longer in production by ACS or the new ECP company. Renew has replaced this model with the introduction of their portable NCP-4 ECP system. However, ACS will continue to provide service and support for their existing ECP customers.
ACS ECP Products
ACS is proven to be a significant player in the U.S External Counterpulsation Therapy marketplace. For more product features of ACS device technology, download our Free“ECP Product Comparison” or visit our “ECP & EECP® Product Reviews“ to read product reviews and see for yourself how ACS device technology stacks up versus the competition.
Legal & Safety Notice
Applied Cardiac Systems has a sound record of manufacturing medical devices in the U.S. for more than 33 years. Although there is no public notices regarding the safety & manufacturing practices of ACS, the competition claims that ACS has documented no proof of any safety accreditation’s such as a CE Mark™ other than ISO 60601 safety compliance.